APA (7th ed.) Citation

Aburub, A., Sperry, D. C., Bhattachar, S., Lobo, E., Ding, X., & Rose, J. P. (2019). Relative Bioavailability Risk Assessment: A Systematic Approach to Assessing In Vivo Risk Associated With CM&C-Related Changes. Journal of pharmaceutical sciences, 108(1), 8-17. https://doi.org/10.1016/j.xphs.2018.07.012

Chicago Style (17th ed.) Citation

Aburub, Aktham, David C. Sperry, Shobha Bhattachar, Evelyn Lobo, Xuan Ding, and John P. Rose. "Relative Bioavailability Risk Assessment: A Systematic Approach to Assessing In Vivo Risk Associated With CM&C-Related Changes." Journal of Pharmaceutical Sciences 108, no. 1 (2019): 8-17. https://doi.org/10.1016/j.xphs.2018.07.012.

MLA (9th ed.) Citation

Aburub, Aktham, et al. "Relative Bioavailability Risk Assessment: A Systematic Approach to Assessing In Vivo Risk Associated With CM&C-Related Changes." Journal of Pharmaceutical Sciences, vol. 108, no. 1, 2019, pp. 8-17, https://doi.org/10.1016/j.xphs.2018.07.012.